Business

Sesame Launches Wegovy® Pill Through Collaboration With Novo Nordisk

NEW YORK, January 22, 2026--SESAME LAUNCHES WEGOVY® PILL THROUGH COLLABORATION WITH NOVO NORDISK

articleNovo Nordisk A/s Class BJanuary 22, 20263/company/novo-nordisk-as-class-b/news/sesame-launches-wegovyr-pill-through-collaboration-with-novo-nordisk
Sesame Launches Wegovy® Pill Through Collaboration With Novo Nordisk

About this update from Novo Nordisk A/s Class B

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/9ad9a5b9b1f73e0d0012b2e94af1e46e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UWFSWYwgcxNLF8c47l67og--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9ad9a5b9b1f73e0d0012b2e94af1e46e","width":480,"height":480},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/yFDey_kaw6tNtcR0bPfXzw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9ad9a5b9b1f73e0d0012b2e94af1e46e","width":480,"height":480}},"lazy":false},{"type":"text","content":"Cash-pay platform brings transparent pricing and direct provider access to first and only oral GLP-1 weight loss medication nationwide","length":134,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, January 22, 2026--(BUSINESS WIRE)--Sesame, the leading cash-pay healthcare platform, announced today that it is working with Novo Nordisk as a NovoCare® Recognized Care Provider on the nationwide launch of the new Wegovy® pill. Patients can visit sesamecare.com or use the Sesame mobile app to schedule an appointment with a provider for access to the first and only oral GLP-1 weight loss medication.","length":411,"tagName":"p"},{"type":"text","content":""The Wegovy® pill, the first and only FDA-approved oral GLP-1, offers patients a convenient new option for their obesity medicine," said Dave Moore, Executive Vice President, US Operations, Novo Nordisk. "Our collaboration with Sesame represents another step forward in giving people more choice, with a simple, direct-to-patient path to care designed around individual needs."","length":397,"tagName":"p"},{"type":"text","content":"Sesame's affordability-first model removes insurance carriers and middlemen, delivering transparent, upfront prices that are often far lower than traditional insurance copays or deductibles. Patients choose their own doctor from Sesame's nationwide network of licensed providers and can book same-day video appointments across all 50 states. With over 1 million patients served to date and a 95 percent satisfaction rating, Sesame is established as a trusted solution for affordable, accessible healt...

More updates from Novo Nordisk A/s Class B

Novo NordiskSesamePatients